TECHNOLOGY.
FASTER.
together.

As more patients seek out advanced therapies that are minimally invasive, highly effective and provide them with a better quality of life throughout treatment, the demand for state-of-the art healthcare services has grown greater than ever before. Unfortunately, the hospitals and physician groups who want to deliver this technology often face a prohibitive capital gap.

Accelitech is an industry leader in the full-cycle management of technology-based treatment centers for cancer care and beyond. We have extensive experience and proven expertise to create a specialized center that will be clinically and financially successful—and get it to market quickly.

Partnerships to Create and Deliver Cutting-Edge
Cancer Treatment Centers

Our partnerships are inspired by technology, driven by experience and sustained by results. With ten separate locations and several more in development, we know exactly what successful technology ventures look like. Because of our regulatory, legal, financial and executive experience, we’re able to accelerate progress and successfully navigate every stage of development.

From feasibility study to equipment procurement, construction oversight to operational management, Accelitech can get you up and running quickly and provide you with the highest likelihood of success. And our vendor-neutral model can be applied to virtually any technology venture, so physicians and hospitals can provide their patients with the latest treatment technology they demand.

A Turnkey Approach to Full-Cycle Management

Business Planning

Accelitech’s legal, financial and medical experts evaluate specific market conditions and produce a comprehensive feasibility study. All the doctors, hospitals, clinicians and investors who will comprise the LLC are assembled, and a structured financial agreement is put in place. Reimbursements are validated, and decisions and recommendations are made as to how the project should move forward.

Feasibility Study
Market Assessment
Legal Evaluation
Regulatory Due Diligence

Financial Modeling
Key Issues Addressed
Recommendations

Partnership Creation

The structured financial agreement is executed, and the partnership is made official. All legal and financial arrangements necessary to take the project from planning to execution are made. In this stage, the LLC is formed and funded, and the project is prepared for construction.

JV Formation and Structure
JV Capitalization
Project Capitalization
Investment Syndication

Equipment Purchase
Regulatory Compliance

Deployment and Project Development

The tactical phase, includes everything from groundbreaking right up to the day the center opens. Our experience with project management allows us to avoid construction barriers that lead to delay, while our operational expertise ensures an efficient organization that is structured for success at every level.

Facility Design
Construction Management
Operational Design and Oversight
Policy and Procedure Development
Staffing

Managed Care Contracting
Acceptance and Commissioning
Physician Training and Credentialing
Marketing and Strategic Planning
Cancer Treatment Center Launch

Program Management and Optimization

The ribbon is cut, and patients begin receiving treatment. But that doesn’t mean our work is done. Accelitech doesn’t just consult on management, we leverage the best business, clinical and corporate practices from our network of cancer treatment centers and take full control of the day-to-day and long-term operations.

Executive Director Selected
Top-down Program Management
Network Development via Physician Liaisons
Executive Marketing Support
Key Metrics and Benchmarking

Research and Protocol Development
High-level Corporate Strategy
Medical Advisory Board Development

The Technology to
Succeed. Accelerated.

With Accelitech, accessing the latest technology and creating a successful specialty program is fast and easy. By working with us as partners, physicians and hospitals can acquire the latest technology and develop successful healthcare programs in an accelerated time frame. As a vendor-neutral company, we can apply our full-cycle management model to virtually any healthcare technology, getting the latest treatment to the most patients in the places it will do the most good.

We understand that strong partnerships are critical to our continued success. That’s why we treat each venture as a long-term relationship, leveraging best practices from our expanding network of healthcare centers to create and maintain a balanced site that benefits all parties. In addition to planning and development, Accelitech will take an active role in both day-to-day and long-term management, so our hospital partners and physicans can do what they do best—help patients.

As technology continues to evolve, newer treatment opportunities may present themselves. Accelitech continually stays ahead of these trends, looking for new ways to help our partners offer patients the best care possible. With our experience, expertise and proven model, we can project a clear picture of any opportunities and provide the solutions to ensure success in each and every venture.

Management

Kerwin J. Brandt, President and Chief Executive Officer, is responsible for leading the Accelitech team, ensuring that key milestones are achieved, maintaining strategic partnerships within the healthcare industry and securing funding necessary for targeted growth. Kerwin also manages the joint venture and technology financing arrangements. Prior to founding Accelitech, Kerwin was the Senior Vice President, Technology Ventures and Chief Financial Officer at NeuroSource. There, he served as head of operations over the
Technology Ventures unit, consisting of a national network of hospital-based stereotactic radiosurgery joint ventures with physicians and hospitals. As CFO, Kerwin managed the financial operations within the company and completed capital raises (including asset-based senior loans, mezzanine financing, subordinated debt, equipment leases, REIT sale leaseback and equity transactions). During his tenure, Kerwin led the financial team in the acquisition and transfer of an 85-bed specialty hospital. He also established and served as a director of the board for an offshore captive insurance company. Prior to joining NeuroSource, Kerwin served as Vice President, Finance and Administration for CallConnect Communications. While at CallConnect, Kerwin directed the concurrent completion of an acquisition of a telecommunication business servicing the healthcare industry and a related debt and equity capital raise. Earlier in his career, Kerwin spent four years with BDO Seidman as an Audit Manager and Manager of Centralized Accounting for Service Master Home Health Care. Kerwin holds an MBA from Illinois Benedictine College in Lisle, Illinois and a BA in accounting with a minor in economics from the University of Northern Iowa. He passed the CPA exam in 1990.
Scott Milligan, Chief Development Officer, is responsible for driving Accelitech's overall business growth. His efforts include the creation of joint ventures with providers and vendors to bring emerging medical technologies to market. Scott works with physicians, senior leadership teams and board members for provider organizations to establish balanced and equitable long-term partnerships. Prior to founding Accelitech, Scott served as Vice President of
Technology Ventures for NeuroSource. There, he created and developed a hospital-based joint venture business for NeuroSource. Through these endeavors, he became a recognized thought leader in the stereotactic radiosurgery market and was active on the national speaking circuit. Prior to NeuroSource, Scott spent five years as a Senior Manager with Cap Gemini Ernst & Young, where he was a national leader in the Physician Services Practice and consistently ranked as a top performer. Scott started his career in the diagnostic imaging business, creating imaging centers in partnership with physicians. Scott spent five years developing and managing a network of centers in the Chicago area, which ultimately resulted in ownership of a site and the successful sale to a publicly traded company in 1995. Scott has a BA in Economics from Ohio Wesleyan University in Delaware, Ohio.
David G. Sheffert, Chief Legal Officer, General Counsel, is responsible for the development, structuring and implementation of the legal structures that accommodate the client's desired joint venture arrangement. His efforts include maintaining a current understanding of the federal and state laws that pertain to hospital and physician joint ventures, leasing structures, syndication strategies and related legal issues. Prior to founding Accelitech, Dave was the former General Counsel and Vice President Legal at NeuroSource.
His responsibilities included corporate governance, structuring and closing all corporate transactions including equity and debt financings, the formation and licensure of a new surgical hospital, structuring and closing multiple SRS technology joint ventures, the formation of an off-shore insurance captive, management of complex litigation, and structuring, closing and unwinding physician practice management arrangements. Prior to NeuroSource, Dave was with the firm Ungaretti & Harris, where his practice focused on insurance, transactional and health care representations, including formation, acquisition and sale of licensed insurance companies, formation of multiple physician and physician/hospital networks, hospital and health system mergers and acquisitions, physician and physician practice representations, provider contracting and information technology transactions and licensing. Prior to joining Ungaretti & Harris, Dave's pre-legal work included eight years of progressive experience in the health and managed care insurance industry, culminating as Senior Underwriter National Accounts, Blue Cross Blue Shield of Illinois. Dave has a JD from Loyola University in Chicago, Illinois and a BS from Indiana University.
James A. Te Winkle, Chief Strategy Officer, is responsible for the development and ongoing operations of Accelitech's joint venture partnerships. Prior to founding Accelitech, Jim was Senior Director of Operations, Technology Ventures at NeuroSource. There, he was responsible for managing a national network of hospital-based stereotactic joint ventures and for developing a standardized operational process for joint venture implementation and
development. Prior to NeuroSource, Jim was the Senior Director of Business Development at Health Forum, a subsidiary of the American Hospital Association (AHA). There Jim was responsible for leveraging the brand value of the American Hospital Association (AHA) by identifying and securing strategic partnership programs and creating sustainable revenue growth through the development of products and services and capitalizing on Internet-based opportunities. Prior to his work at Health Forum, Jim was the Director of Client Solutions, CorSolutions, Inc., where he developed a standardized process and clinical outcome reporting system. He also led the strategic development process for current and new business initiatives. Earlier in his career, Jim held a number of clinical positions within the outpatient cardiovascular setting and in hospital-based oncology programs. Jim holds an MBA, with a specialization in healthcare, from Lake Forest Graduate School of Management in Lake Forest, Illinois; an MS in Exercise Science and Cardiovascular Research from Northeastern Illinois University in Chicago, Illinois, and a BS in Nursing from Hope College in Holland, Michigan.
James R. Williams, Chief of Operations, Client Services, oversees the day-to-day operations and growth initiatives for Accelitech’s network of cancer centers. His efforts include developing the corporate infrastructure, systems, and processes that will lead to best-in-class practices and market leadership positions for the network. He is a skilled healthcare executive with more than 20 years of experience with start-ups and turnarounds within a variety of healthcare spaces. Prior to joining Accelitech, James served as the President for The CDH Proton Center, a ProCure Center. There, he successfully completed the construction and launching of the nation’s ninth Proton Therapy Center. He established industry leading patient ramp up and complexity while creating a national and international hub with patients from more than 22 states and six countries. Prior to ProCure, James served as COO for RMS Lifeline, a wholly owned subsidiary of DaVita, and as COO of Vein Clinics of America, where he built the operational infrastructure, growth, and market expansion plans while positioning the company for its successful sale in 2008. James was also a member of the startup team for NovaMed, where he served on the Senior IPO team that successfully took the company public. Additionally, James continues to assist healthcare incubators, accelerators, start-ups, and private equity investors. James graduated from Ohio University with a BBA in Hospital Administration and received his MBA in Healthcare Administration from Benedictine University, where he graduated first in his class.

developing a center

Our full-cycle management model enables physicians and hospitals to acquire and deliver the latest healthcare technology to patients quickly and with minimal risk and capital outlay. Each venture is supported by our equipment and financing partners and backed by our management expertise, clinical network and reputation for long-term success. Together, we can deliver patients the best care using the latest technology and unprecedented timeframe.

Thoracic Surgeons
Neurosurgeons
Radiation
Oncologists
Urologists

Access to capital
Non-recourse structures
Speed to market
Vendor knowledge and neutrality
Limited financial risk
Turnkey support and management

Our Partners

Page 1234567

News

Radiosurgery Veteran Randy Miller Joins the Expanding Accelitech Development Team
Jim Te Winkle to Assume Position of Chief Strategy Officer
Penny Hoglund Joins Expanding Accelitech Operations Team
Accelitech Welcomes Chief of Operating-Client Services, James Williams
Accelitech Welcomes Regional Vice President of Business Development, Tom Maher
Prostate Cancer Study Using SBRT Technology
Mortenson Construction Retrofits Chicago High-Rise To Accommodate State-of-the-Art CyberKnife Cancer Institute of Chicago
CyberKnife Cancer Institute of Chicago Is the First to Offer CyberKnife Treatment in the City of Chicago
Swedish opens first downtown location, expands services
Accelitech: FDA Approves Mevion Medical System’s Proton Beam Technology
Accelitech Partners with St. Francis Hospital to Bring CyberKnife Center to Memphis
Accelitech Expands into Europe, Partners to Create First CyberKnife® Center in Ireland
Accelitech to Open the First CyberKnife Cancer Center Within the City of Chicago
Accelitech: Now Delivering Cancer Treatment at Two-thirds the Speed of Light
Accelitech Launches Elite Oncology Consulting
Accelitech expands its partnership in Louisiana by adding new Varian True Beam Technology
Accelitech adds 2nd Varian True Beam to its network through a new physician partnership in Tucson, AZ
Accelitech’s 2nd New Jersey CyberKnife Site Commences Operations
Accelitech’s 7th CyberKnife Opens in Miami
Accelitech to Launch its 6th CyberKnife Program in Partnership with Saint Peter's University Hospital in New Brunswick, NJ
Accelitech to Sponsor Customer Service Workshop at Accuray User Meeting
Accelitech Announces Launch of its Elite Management System
Accelitech Financing Remains Strong Despite Credit Market Turmoil
Accelitech Presents at 2008 Cancer Center Business Summit
Accelitech's Fifth CyberKnife Center to Open in Colorado Springs

Case Studies

Accelitech is the industry leader in full-cycle management of ventures to secure proton beam therapy, SRS technology and other cutting-edge healthcare programs. With ten existing locations and several more in development, we are among the fastest-growing private developers in the country.

Physician-driven Venture

A group of physicians approached Accelitech seeking to bring emerging technology, Sterotactic Radiosurgery (SRS), to a relatively small southern market through a regulatory compliant ownership model. Read more >

Accelitech Partnership Delivers State-of-the-Art Treatment in Lafayette, Louisiana While Stereotactic Radiosurgery (SRS) applications continue to expand from intracranial to extracranial cancers, physician interest in the technology is also on the rise. Two years ago, a group of physicians in Lafayette, Louisiana sought to bring SRS to their small regional market but lacked the tools and resources to make it happen.

The physicians, in conjunction with a local hospital, Lafayette General Medical Center, partnered with Accelitech to open the CyberKnife Center Louisiana. The center possesses the first and only CyberKnife G4 model in the region, employing technology that allows for enhanced imaging and tumor tracking capability and higher treatment doses.

Accelitech created a joint venture model that enabled the physicians to obtain SRS technology quickly and with minimal capital outlay. As a developer, Accelitech provided the expertise to establish the venture quickly and drive long-term success. Owning a minority interest in the equipment, Accelitech assumes risk along with the physician partners.

Since opening in April 2007, the CyberKnife Center Louisiana has been a favorable addition to the Lafayette community. Before the center, patients drove to Houston or New Orleans to receive treatment; now, patients can stay in the community and receive the best treatment possible. “Accelitech provided the knowledge, structure, financing and focus to effectively execute our vision to bring the CyberKnife to central Louisiana,” says Dr. Alan Appley, a neurosurgeon and co-director of the program.

The specialties represented at the center are broad, from radiation oncology to pulmonology to otolaryngology (ENT) and medical oncology. The center treats patients with neurological conditions such as trigeminal neuralgia, arteriovenous malformation, acoustic neuromas and cancer anywhere in the body.

“There is a huge capital gap today,” says Kerwin Brandt, President and Chief Executive Officer of Accelitech. “The technology is available and changing all the time, yet hospitals and physicians need the capital to be able to acquire this technology.”

Joint ventures of this type need to be carefully structured to comply with federal Stark and anti-kickback laws and regulations. Through the Accelitech model, existing providers get an experienced partner and the opportunity to acquire, finance and commercialize new technology for the optimal treatment of patients. Read Less >

Hospital-driven Venture

A large academic hospital was facing capital challenges that threatened their ability to remain competitive. Read more > Accelitech Partnership Helps Capital-constrained Hospital to Open SRS Center.

Scenario:
A large academic hospital was facing capital challenges that threatened their ability to remain competitive. Capital is constrained and is projected to be the biggest barrier for the hospital over the next 30 years. Further, physicians are both supporters of hospitals and potential competitors. As models and opportunities have emerged wherein physicians can develop independent facilities to provide anything from imaging to surgery, hospital margins have eroded.

The hospital administrator was seeking ways to creatively secure the technology they needed to be competitive and partner with their physicians in a meaningful, regulatory-compliant manner. Stereotactic radiosurgery represented an opportunity to grow the hospital’s bottom line with limited risk, enfranchising physician constituents for the benefit of the patients they serve.

Accelitech was hired by the hospital to evaluate the market for stereotactic radiosurgery and provide options for joint ventures with their physicians. Specialists with emerging interest in this new technology included neurosurgeons, radiation oncologists and urologists.

Joint Venture Solutions Accelitech created the business plan and structures to allow the hospital to partner with their physicians. Key benefits to an Accelitech partnership include:

• Hospital becomes the SRS end provider
• Limited capital investment required by all parties
• Limited volume risk for hospital
• Physicians participate in ownership structure
• Non-recourse loans do not require cumbersome guarantees for hospital or physicians
• Accelitech handles legal, business, financial and clinical development
• Speed to market

Our team can help you to make the right decision and create the models that limit your risk, maximize returns and create access for your patients in an accelerated time frame. Read Less >

Free-Standing SRS Center

A large neurosurgeon group in Tucson, Ariz., wanted to expand itscapabilities to include radiosurgery technology. Read more > Accelitech Partners with Two Physician Groups to Develop Free-Standing SRS Center

A large neurosurgeon group in Tucson, Ariz., wanted to expand its capabilities to include radiosurgery technology. They sought to create a center where they could provide treatment for complicated and inoperable tumors in the head and brain, but also control the quality of the service and patient experience. They knew that the demand for the technology was there, but on their own, they didn’t have the volume to warrant buying a device.

That’s when they approached Accelitech.

Relying on extensive experience and development expertise, Accelitech quickly put together a plan. A busy group of urologists in the area was also interested in offering radiosurgery as an option to patients, but faced a similar gap as the neurosurgeons. By securing a relationship between the two groups and creating a special-purpose financing entity, both parties would be able to deliver SRS treatment. Under the conditions of the joint venture, the two groups would share ownership and access to the infrastructure and technology, but use it to treat their patients separately.

The arrangement was unique because SRS center would be free-standing, meaning development would take place without the investment or participation of a hospital partner. Although radiation oncologist groups often develop their own sites, this would mark the first time that a neurosurgeon group would create their own free-standing treatment center.

Accelitech secured non-recourse financing for the venture and procured the technology. TrueBeam™ by Varian Medical Systems is an advanced radiotherapy machine that targets tumors with higher doses of radiation in precisely defined areas, making it possible to treat more patients with more types of cancer. TrueBeam™ therapy is painless, non-invasive and highly effective in treating tumors while minimizing damage to surrounding healthy tissue.

Employing its turnkey approach to full-cycle management, Accelitech guided the center from financing to first patient, including the oversight and management of construction, staffing and operations. The physicians, some of which previously did not have experience with radiation oncology services, were trained on the technology.

The TrueBeam™ center in Tucson began treating patients in spring of 2012, just 15 months after the neurosurgeons first engaged Accelitech. Per the terms of the partnership, Accelitech continues to manage the operations of the facility and the equipment, leaving the physicians to do what they do best: help patients. The center has proven to be a success, and thanks to this Accelitech joint venture, more patients in Tucson are able to receive the high-tech treatment they need to get well while maintaining a high quality of life.
Read Less >

TECHNOLOGY. FASTER. together.

Partnerships to Create and Deliver Cutting-Edge Cancer Treatment Centers

The Technology to Succeed. Accelerated.